EDA and X-linked hypohidrotic ectodermal dysplasia: In mouse and dog XLHED models, administration of a single course of an EDA-A1 replacement protein (EDI200) resulted in permanent correction of the key phenotypic features, providing the first hope for effective, targeted therapy.